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What is the key question? 
Are actigraphic sleep measures associated with disease severity, exertional dyspnea, gender, and 
parts of the week (i.e. weekdays vs. weekends); and is there an association between assessed 
sleep measures and next day physical activity? 
What is the bottom line? 
Actigraphic sleep measures in patients with COPD were found i) to be worse in patients with 
severe airway obstruction and dyspnea; ii) to be associated with the amount of physical activity 
the  subjects undertake during the following waking day.   
Why read on? 
With poor sleep and physical inactivity each recognized as key public health priorities, this 
research has shown that poor sleep, assessed under free living conditions, may hamper efforts of 
patients with COPD to be physically active, emphasizing a relationship between sleep and daily 
physical activity. 
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Abstract  
Background Sleep disturbances are common in patients with chronic obstructive pulmonary 
disease (COPD) with a considerable negative impact on their quality of life. However, factors 
associated with measures of sleep in daily life have not been investigated before nor has the 
association between sleep and the ability to engage in physical activity on a day-to-day basis 
been studied. 
Aims To provide insight into the relationship between actigraphic sleep measures and disease 
severity, exertional dyspnea, gender, and parts of the week; and to investigate the association 
between sleep measures and next day physical activity. 
Methods Data were analyzed from 932 patients with COPD (66% male, 66.4±8.3 years, FEV1 % 
predicted = 50.8±20.5). Participants had sleep and physical activity continuously monitored 
using a multi-sensor activity monitor for a median of six days. Linear mixed effects models were 
applied to investigate the factors associated with sleep impairment and the association between 
nocturnal sleep and patients’ subsequent daytime physical activity. 
Results Actigraphic estimates of sleep impairment were greater in patients with worse airflow 
limitation and worse exertional dyspnea. Patients with better sleep measures (i.e. non-fragmented 
sleep, sleeping bouts ≥225 minutes, sleep efficiency ≥91% and time spent awake after sleep 
onset <57 minutes) spent significantly more time in light (p<0.01) and moderate-to-vigorous 
physical activity (p<0.01).  
Conclusions There is a relationship between measures of sleep in patients with COPD and the 
amount of activity they undertake during the waking day. Identifying groups with specific sleep 
characteristics may be useful information when designing physical activity enhancing 
interventions. 
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Introduction  
In addition to progressive chronic airflow limitation, patients with chronic obstructive pulmonary 
disease (COPD) commonly have multiple extrapulmonary effects and comorbidities, which are 
associated with physical inactivity.[1] Although there is general agreement about the need to 
assess and improve physical activity in people with COPD, the factors associated with patient’s 
capability to engage in physical activity are not well established, which may limit the impact of 
physical activity enhancement interventions.[2] 
 
Sleep disturbance, such as sleep fragmentation during the night, is common in patients with 
COPD,[3] and is a major complaint after dyspnea and fatigue.[4] Despite the high prevalence of 
disturbed sleep in COPD, nighttime symptoms are often underestimated and are not a focus of 
current disease management.[3]  
 
Activity-based or actigraphy sleep-wake monitoring is a cost-effective method to assess sleep 
that has gained a central role in clinical sleep research, and sleep medicine [5] by proving 
invaluable insights for the improvements of individualized treatment decisions.[6] Although 
actigraphy should not be viewed as a substitute for sleep diaries or overnight polysomnography, 
it can provide useful information about sleep in the natural sleep environment if used for 
extended period of time with minimal participant burden.[7]  
 
Nocturnal sleep, studied by actigraphy, has been shown to be markedly impaired in patients with 
COPD compared to controls.[8] However, there is scant and discordant information on whether 
actigraphic measures of sleep worsen as the severity of dyspnea and airflow limitation 
increases.[8, 9] Therefore, more data are needed for a better understanding of the factors 
associated with sleep impairment in patients with COPD. Moreover, although sleep disturbance 
likely contributes to daytime symptoms like chronic fatigue, lethargy and overall impairment in 
quality of life described by these patients,[10] no published study has objectively investigated the 
association between nighttime sleep measures and measures of spontaneous physical activity the 
following day.  
 
In this study, data were pooled from different studies resulting in a large sample of patients with 
mild to very severe COPD who had extended objective measures of sleep and physical activity 
during daily life assessed using a multi-sensor activity monitor. These data were used to: (1) 
provide insight into the relationship between objectively determined sleep measures and disease 
severity, exertional dyspnea, gender, and parts of the week (i.e. weekdays vs. weekends); and (2) 
investigate whether there was an association between objectively assessed sleep measures and 
next day physical activity. Our hypotheses were that patients with more severe COPD defined 
according to the Global Initiative for Chronic Obstructive Lung Disease (GOLD) [11] criteria 
and higher Modified Medical Research Council (MMRC) [12] dyspnea score would have more 
objectively measured sleep disturbances, and that nights of impaired sleep would be followed by 
days characterized by lower levels of physical activity. 
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Methods 
Study design and participants 
In this retrospective, cross-sectional study data from previous studies (details can be found in the 
appendix pp. 3-5) were obtained from research groups in ten countries: Europe (The 
Netherlands, UK, Switzerland, Germany, Italy, Ireland, Spain); North America (USA); South 
America (Brazil); and Oceania (Australia). Criteria to include participants in the current analyses 
were: clinically stable COPD (i.e., stable shortness of breath and sputum production) with a post-
bronchodilator ratio of forced expiratory volume in the first second (FEV1) to forced vital 
capacity (FVC) < 0.70; no COPD exacerbations within the last 30 days; and availability of sleep 
and daytime physical activity baseline data recorded in daily life using the SenseWear Armband 
or SenseWear Mini Armband activity monitors (BodyMedia Inc., Pittsburgh, PA, USA) before 
any specific interventions were undertaken. The SenseWear Armband (SWA) has been 
previously used to study the circadian pattern of sleep and skin temperature,[13] to assess sleep 
pattern in patients with acute coronary disease,[14] and to monitor sleep in COPD.[15, 16, 17] 
Data from 1384 patients were available for the present study. The data collection was conducted 
in accordance with the declaration of Helsinki and approved by ethics committees at each of the 
participating centers, according to local regulations. Written informed consent was provided by 
all participants.  
Data recordings 
Study participants wore the SWA on the upper arm both during daytime and nighttime so that 
continuous data related to sleep and real-life activities were recorded.  
While worn, the SWA recorded continuously longitudinal and transverse acceleration, skin 
temperature, near body temperature, heat flux, and galvanic skin response. Collected data sent to 
a PC were used to calculate the metabolic equivalent of task (MET), number of steps, posture 
(lying down vs. not lying down) and sleeping status (sleep vs. wakefulness) on a minute-by-
minute basis.[18] The use of multisensory data in combination with pattern recognition 
algorithms ensured that the MET estimation was insensitive to noise and random motion 
artefacts [19] and allowed the objective assessment of sleep [20] and daytime activity levels.[21]  
METs data were divided into activity intensity levels using the thresholds proposed by the 
American College of Sports Medicine: very light intensity, < 2.0 METs; light intensity, 2.0 to 2.9 
METs; and moderate-to-vigorous intensity, ≥ 3.0 METs.[22]  
Time in bed and time out of bed were derived from the minutes coded by the activity monitor as 
“sleeping” and “lying down” using a custom-made algorithm (appendix pp. 6-9). Based on these 
data the following nighttime and daytime sleep measures were derived: total night sleeping time, 
number of nocturnal sleeping bouts, duration of nocturnal sleeping bouts, sleep efficiency, wake 
after sleep onset, total day sleeping time, number of daytime sleeping bouts, and average 
duration of daytime sleeping bouts. Sleeping bouts were defined as consecutive minutes marked 
by the sensor as sleeping. In this study, “sleep quality” is used to refer to the collection of these 
sleep measures with definitions presented in Table 1. 
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Table 1 Nocturnal and daytime sleep measures derived from actigraphy data. 
Variable name Abbreviation Description 
Total Night Sleeping 
Time 
TNST 
Total night sleeping time is calculated as the sum of all minutes scored as 
sleep during time in bed.  
Number of Nocturnal 
Sleeping Bouts 
NNSB 
Number of nocturnal sleeping bouts during time in bed. A higher NNSB 





Average duration of nocturnal sleeping bouts during time in bed. A higher 
DNSB indicates longer sleeping bouts, and, in turn less nocturnal sleeping 
disturbances. 
Sleep efficiency Seff Sleep efficiency defined as the ratio of TNST and time in bed. 
Wake After Sleep 
Onset 
WASO Time spent awake during time in bed after the first nocturnal sleep onset. 
Total Day Sleeping 
Time 
TDST 
Total day sleeping time defined as the total time spent asleep during the out 
of bed period. 
Number of Daytime 
Sleeping Bouts 
NDSB 
Number of daytime sleeping bouts indicates how many naps a patient takes 
during the day. 
Duration of Daytime 
Sleeping Bouts 
DDSB 
Average duration of daytime sleeping bouts during the day. A higher DDSB 
indicates longer naps. 
 
As physical activity measures, the number of steps performed during daytime and the time spent 
in very light, light and moderate-to-vigorous activities were computed for each assessed day.  
Participants who wore the SWA for at least 22 hours per day, with a minimum of four assessed 
consecutive days (two weekdays + Saturday + Sunday) were included.[21] Participants who did 
not have their sleep regularly distributed during nighttime or who had less than four hours of 
time in bed were excluded in order to minimize possible errors due to methodological 
limitations. For these patients it was not possible to find a reliable estimation of the time in bed 
and time out of bed as explained in the appendix pp. 6-9.  
Statistical analysis   
Since physical activity can vary from day to day, complex effects and interactions are expected 
to occur, which creates the need for multiple days of measurements and proper statistical 
approaches to identify associations with sleep. Linear mixed-effect models (LMM) were used to 
study: (i) which factors influenced sleep quality measures, and (ii) whether and to what extent 
sleep quality measures were associated with subsequent daily physical activity levels and 
daytime sleep. This kind of multilevel analysis was chosen to account for repeated measurements 
and control for several confounding factors such as disease and dyspnea severity, current 
smoking status at the time of enrolment, country, gender, parts of the week (i.e. weekdays and 
weekends), age, and body mass index (BMI). To construct the models standard statistical 
packages were used (details can be found in the appendix p 12). Similar analyses were carried 
out in.[23, 24, 25] Least squares means (LS-means) and differences of LS-means of the fixed 
effects were calculated to present the results. Degrees of freedom and p-values for significant 
differences (significant if p<0.05) were computed using Satterthwaite’s approximation.[26] 
Comparisons of demographic and clinical characteristics between included and excluded patients 
were evaluated by Mann-Whitney U-test for continuous variables and Chi-square test for 
categorical variables. Analyses were carried out using MATLAB R2015a (The MathWorks, Inc., 
Natick, Massachusetts, United States) and R (R Core Team, 2012) software.  
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Results   
In total 932 patients with COPD were eligible for analysis. Figure 1 shows the flow of 
participants through the study. Patients excluded due to irregular sleeping patterns and not 
enough time in bed had significantly lower FEV1 % predicted compared with included patients 
(46.6±19.4 vs. 50.8±20.5, p<0.05). No significant differences between included and excluded 
patients were observed for age, gender, BMI, smoking status at enrollment and MMRC. The 
median number of days analyzed per patient was six (four weekdays + Saturday and Sunday), 
resulting in a total of 5646 valid assessed days, of which 3788 (67%) were weekdays. 
Demographic and clinical characteristics of the patients included in the study are presented in 
Table 2 (those of excluded patients can be found in Supplementary Materials Table 1, appendix p 
11).  
Table 2: Demographic and clinical characteristics. 
 Included patients (n=932) 
Male / female (%) 66 / 34 
Smokers* / never or former smokers** (%) 33 / 67 
Age  (yr) 66.4±8.3 
BMI (kg/m2) 26.3±5.4 
FEV1 % predicted 50.8±20.5 
GOLD 1 - 2 - 3 – 4 (%) 10 – 40 – 32 – 18 
MMRC*** 0 - 1 - 2 - 3 – 4 (%) 14 – 27 – 22 – 18 – 6 
Data in the table are expressed as percentages, or means ± standard deviation.  BMI: Body Mass Index, FEV1: 
forced expiratory volume in 1 s, GOLD: Global Initiative for Chronic Obstructive Lung Disease grade, MMRC: 
modified Medical Research Councils scale.*Current smokers at the time of enrollment. **Never or former smokers 
at the time of enrollment. ***MMRC data for 805 patients. 
 
Sleep measures evaluation in patients with COPD  
Figure 2 shows the associations of nighttime and daytime sleep measures with disease severity, 
dyspnea, gender, and parts of the week. In particular, the total night sleeping time (Fig. 2A) was 
significantly higher in women (p<0.01) and during weekends (p<0.01). The number of nocturnal 
sleeping bouts (Fig. 2B) increased both with airflow limitation and exertional dyspnea. Patients 
with the most severe airflow limitation and exertional dyspnea had significantly more 
fragmented sleep than patients with the lowest GOLD grade (p<0.01) and MMRC score 
(p<0.05). The number of nocturnal sleeping bouts was significantly higher in men (p<0.001) and 
during weekends (p<0.05). Both short duration of nocturnal sleeping bouts and low sleep 
efficiency were associated with a higher GOLD grade and dyspnea score (Fig. 2C-D). Patients 
with the most severe airflow limitation had significantly shorter sleeping bouts (p<0.05) and 
lower sleep efficiency (p<0.01) than patients classified as GOLD 3. Patients reporting the highest 
MMRC score had significantly shorter sleeping bouts (p<0.05) and lower sleep efficiency 
Page 10 of 19 
 
(p<0.01) compared to patients with lower MMRC scores. Duration of sleeping bouts and sleep 
efficiency were significantly higher for women (p<0.001). The time spent awake after the first 
sleep onset (Fig. 2E) increased both with disease severity and dyspnea, being worst in patients 
with GOLD grade 4 (p<0.05) and MMRC score 4 (p<0.01).  
During daytime (Fig. 2F-H) the sleeping time, the number and duration of sleeping bouts 
increased significantly with dyspnea (p<0.05). Sleeping time and duration of sleeping bouts were 
significantly shorter in patients with GOLD grade 4 compared to patients classified as GOLD 3 
(p<0.05). 
Association between objective sleep measures and daytime physical activity 
Nocturnal sleep measures were divided into quartiles (Q1, shortest/lowest-Q4, longest/highest) to 
assess the association with daytime physical activity measures (Supplementary Materials Table 
2, appendix p 13). 
As shown in Fig. 3A, the number of steps performed during the day was inversely related to the 
number of sleeping bouts and the minutes spent awake after the sleep onset. On the other hand, 
the number of steps increased as the duration of the sleeping bouts and the sleep efficiency 
increased. In particular, patients who had their sleep characterized by one sleeping bout, long 
sleeping bouts (≥225 minutes), high sleep efficiency (≥91%), and low time spent awake after the 
sleep onset (<57 minutes) performed, on average, 600 steps more on the following day with 
respect to patients who had more fragmented sleep (≥4 bouts), lower sleep efficiency (<71%), 
lower sleeping bout durations (<86 min) and higher time spent awake after the sleep onset (≥165 
minutes) (p<0.001 for all). Patients who slept more than 480 minutes performed a smaller 
number of steps than the other patients, but no significant differences were found if the number 
of steps of each patient is divided by the time spent awake (data not shown). As presented in Fig. 
3B, the percentage of daytime spent in very light activities was higher in patients who slept more 
than 480 minutes and it increased with sleep fragmentation, and time spent awake after the sleep 
onset. Furthermore, the time spent in very light activities decreased as sleep efficiency and 
duration of sleeping bouts increased. Patients with the worst nocturnal sleep measures (i.e. sleep 
characterized by sleeping bouts <86 minutes, sleep efficiency <71%, and time spent awake after 
the sleep onset ≥165 minutes) spent on average the 74% of the time awake in very light intensity 
activities, 1% more than patients with sleep characterized by sleeping bouts ≥225 minutes 
(p<0.01), sleep efficiency ≥91% (p<0.001), and time spent awake after the sleep onset <57 
minutes (p<0.01). 
Patients with the smallest number of sleeping bouts per night, longest sleeping bouts, highest 
sleep efficiency and shortest time spent awake during the night spent more time in light (Fig. 3C) 
and moderate-to-vigorous (Fig. 3D) physical activities on the following day (p<0.01 for all). In 
particular, compared to patients with the worst sleep measures, these patients spent on average 9 
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minutes more in light intensity activities and 8 minutes more in moderate to vigorous activities 
that correspond to the 26% of the recommended daily amount.[27]  
Daytime sleep was inversely related to the amount of nocturnal sleep, the duration of sleeping 
bouts and the sleep efficiency (Fig. 4). Patients who showed relatively short sleep duration 
during the night (<347 minutes), who had short sleeping bouts (<86 minutes) and low sleep 
efficiency (<71%) reported more daytime sleep compared to subjects who slept more than 480 
minutes during the night (p<0.001), had sleeping bouts longer than 225 minutes (p<0.05) and a 
sleep efficiency higher than 91% (p<0.05).     
Discussion  
We describe, to our knowledge, the first study in a large sample of participants with COPD, 
targeting the association of objectively measured sleep impairment with airflow limitation, 
exertional dyspnea, gender, parts of the week and daytime activity levels. 
We found that objective sleep quality measures are worse in patients with severe airway 
obstruction and dyspnea. This is in agreement with George et al.[28] who showed that subjective 
sleep disturbances tend to be more severe with advanced COPD and with Dodge et al.[29] who 
showed that patients with dyspnea are more likely to report persistent sleep disturbance. 
Conversely, Hartman et al.[9] failed to find a significant association between night’s rest 
parameters assessed by an accelerometer and both airflow limitation and dyspnea. However, this 
latter study did not evaluate sleep quality measures, but rather quantitative parameters such as 
body movements and number of posture transitions that are not necessarily related to poor sleep 
quality.[9] Nunes et al.[8] reported that the MMRC score was an important predictor of 
objectively measured sleep quality in 26 patients with moderate to very severe COPD. However, 
the small sample size precluded any firm conclusions on the differences between patients with 
different dyspnea scores.    
The strong evidence provided by our findings regarding the association of sleep impairment with 
the most severe stage of the disease and dyspnea could be explained by several potential 
mechanisms. First, it is intuitively apparent that because severe COPD patients have a lower 
oxygen saturation during wakefulness, the normal ventilation changes that occur with sleep 
exacerbate this preexisting state to the point of severity impairing sleep.[30] Second, the lying 
sleeping position assumed by the participants in the study and the reduction in muscle tone 
causes increased upper airway resistance.[30, 10] This might have more impact in patients who 
are least able to tolerate any further challenge to their ventilatory capability. Moreover, patients 
with severe COPD frequently experience episodes of worsening symptoms that may also 
preclude from adequate sleep.   
Participants with the most severe disease had worse sleep but they did not seem to compensate it 
during the day by adding naps. Most dyspneic patients, in turn, seemed to do so. Other 
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investigators have also found that daytime sleepiness was related more strongly to the presence 
of respiratory symptoms than to a diagnosis of lung disease or the degree of airway 
obstruction.[31] 
We saw significant gender differences after correction for age, BMI, smoking status at 
enrollment, country of origin, GOLD and MMRC. Men had worse sleep quality measures and 
spent more time sleeping during the day than women. There is currently only limited information 
regarding the influence of gender on sleep in COPD. In a previous study using actigraphy no 
significant gender-related differences in sleep quality were found.[8] Other studies have 
documented that women appear to report more sleep-related complaints.[32] However, objective 
and subjective assessments of sleep seem to reflect different aspects and need therefore not be 
necessarily in agreement.[33]  
During weekends patients had significant more fragmented sleep and spent significantly more 
time awake after the first sleep onset than during weekdays. Our results showed that impaired 
sleep during weekends was compensated by sleeping longer. 
This study showed that nights of lower sleep quality were followed by days of lower levels of 
physical activity in people with COPD. It is important to note that potential influence of airflow 
limitation, severity of dyspnea smoking status at enrollment, country, gender, parts of the week 
(i.e. weekdays and weekends), age, and BMI was taken into account since these variables were 
included in the multilevel models used. 
The association of impaired sleep with worse daytime performance is consistent with findings 
showing that it plays a substantial role in reduced quality of life in patients with COPD.[34, 35] 
Moreover these findings are consistent with other correlational evidence drawn from older adults 
suggesting that objectively measured poor sleep was associated with worse daytime physical 
function evaluated in clinical settings,[36, 37] yet none of these studies demonstrates a direct 
effect of sleep on subsequent physical activity during daily life. Although inferring a causal 
relationship was out of the scope of this study, our finding provided a good illustration of the 
sequential association as it incorporated a clear chronological order of the predictor (sleep 
quality measure) and the predicted variable (physical activity). However, the possibility that poor 
daytime performance may be a causative factor for poor sleep quality should be considered. In 
this regard, it has been previously shown that patients who are most hypoxaemic when awake are 
most severely hypoxaemic when asleep with the consequence of having both reduced physical 
activity during the day and sleep disturbance during the night. On the contrary, in patients with 
mild (or absent) daytime hypoxaemia, this nocturnal desaturation is, in most cases, slight to 
moderate.[30] 
The deficit in good sleep, in association with changes of sleep architecture, may make sleep not 
as restorative as needed and may cause a significant sleep deficit.[38] Accordingly, our study 
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provides evidence to suggest that poor sleep efficiency and short sleeping bouts during the night 
are possibly compensated by additional daytime naps.  
The fact that poor sleep quality was associated with reduced physical activity levels may have 
important consequences with regard to current clinical practice. First, our findings suggest the 
possibility of increasing spontaneous engagement in physical activity through improving sleep 
since, in the absence of any intervention, patients having had a better night of sleep 
spontaneously engaged in more physical activity the following day. Second, existing strategies 
for promoting physical activity tend to focus on actions during the day. Additional efforts in 
promoting quality sleep among physically inactive subgroups may increase the overall impact of 
these interventions. Finally, sleep should be assessed and taken into account when analyzing 
physical activity in COPD, although recent literature is often-overlooking the continuity between 
nighttime sleep and daytime physical activity.[39]  
This study has some limitations which should be considered when interpreting the results. First, 
data regarding exacerbations, hospitalizations frequency and smoking history prior to enrolment 
was not available which prevented to investigate their potential impact on daytime physical 
activity and sleep disruption. Our participants were not screened for sleep-related disorders, such 
as obstructive sleep apnea (OSA). However, because COPD and OSA are both common chronic 
conditions, these should be expected to occur together, particularly among overweight 
individuals with COPD.[40] Moreover, no significant differences were previously found in 
measures of dyspnea, sleep quality, sleep efficiency, and sleepiness during the day between 
patients with COPD only and patients with COPD-OSA overlap.[40] Although we cannot know 
whether the patients included had OSA, we can rule out that specific interventions influenced 
quality or quantity of sleep since only baseline data were analyzed.  
To the current authors’ knowledge, the SenseWear armband has not been properly validated to 
study sleep in COPD. However, several days of assessment reduce the inherent measurement 
errors in actigraphy and further increase the reliability.[5] Moreover, although it has been shown 
to be a reliable method for determining sleep in patients with sleep-breathing disorders when 
compared against polysomnography,[20] the SenseWear armband might underestimate the time 
spent sleeping for those patients who sleep in a sitting position in order to facilitate their 
breathing.  
In summary, sleep impairment in patients with COPD tends to be more pronounced in patients 
with severe airflow limitation and in those with worse exertional dyspnea. Moreover, nocturnal 
sleep impairment appears to be an important factor associated with the capability to engage in 
physical activity on a day-to-day basis. In particular, nights of better sleep quality measures were 
followed by days of higher levels of physical activity. Further research is needed to identify the 
causal association between nighttime sleep and the decline in daytime physical activity, as well 
as to assess whether the management of nighttime symptoms and the reduction of sleep 
impairment can facilitate the adoption of a physically more active lifestyle in patients with 
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COPD. Considering both our current understanding of the negative health consequences of sleep 
disturbance in COPD and the current limited efficacy of interventions in significantly improving 
and maintain physical activity enhancement, our data suggest that approaches to improve sleep 
need to be considered as additional targets for tailored interventions in patients with COPD since 
may have significant implications for facilitating greater adherence and a favorable impact on 
lifestyle.  
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Figure legends 
Figure 1 Flow of patients through the study. 
Figure 2 Impact of disease severity according to Global Initiative for Chronic Obstructive Lung 
Disease (GOLD) grades, daytime dyspnea according to the modified Medical Research Council 
(MMRC) scale, sex (f = female, m = male), and parts of the week (wd = weekdays, we = 
weekends) on sleep parameters (A: Total Night Sleeping Time; B: Number of Nocturnal 
Sleeping Bouts; C: average Duration of Nocturnal Sleeping Bouts; D: Sleep efficiency; E: time 
aWake After the first Sleep Onset ; F: Total Day Sleeping Time; G: Number of Daytime 
Sleeping Bouts; H: average Duration of Daytime Sleeping Bouts). Data are expressed as least-
square means ± standard error. Significance levels for pairwise comparisons are indicated as 
horizontal bars with *=p<0.05, **=p<0.01, and ***=p<0.001. 
Figure 3 Association between nocturnal sleep parameters (Total Night Sleeping Time; Number 
of Nocturnal Sleeping Bouts; average Duration of Nocturnal Sleep Bouts; Sleep efficiency; time 
aWake After the first Sleep Onset) and daytime physical activity measures (A: STEP = Steps 
performed; B: TIME VL = Time spent in Very Light activity, C: TIME L = Time spent in Light 
activity, D: TIME MV = Time spent in Moderate-to-Vigorous activity). Data are expressed as 
least-square means ± standard error. Significance levels for pairwise comparisons are indicated 
as horizontal bars with *=p<0.05, **=p<0.01, and ***=p<0.001. TIME VL, TIME L, TIME VM 
are presented in % of the out of bed time. 
Figure 4 Association between nocturnal sleep parameters (Total Night Sleeping Time; Number 
of Nocturnal Sleeping Bouts; average Duration of Nocturnal Sleeping Bouts; Sleep efficiency; 
time aWake After the first Sleep Onset) and Total Day Sleeping Time. Data are expressed as 
least-square means ± standard error. Significance levels for pairwise comparisons are indicated 
as horizontal bars with *=p<0.05, **=p<0.01, and ***=p<0.001. Total Day Sleeping Time is 
presented in % of the out of bed time. 
 
